share_log

Earnings Report: Satellite Chemical Co.,Ltd. Missed Revenue Estimates By 5.0%

Earnings Report: Satellite Chemical Co.,Ltd. Missed Revenue Estimates By 5.0%

收益报告:卫星化学公司, Ltd. 收入未达到预期5.0%
Simply Wall St ·  03/27 21:34

Shareholders might have noticed that Satellite Chemical Co.,Ltd. (SZSE:002648) filed its annual result this time last week. The early response was not positive, with shares down 3.4% to CN¥16.68 in the past week. Revenues came in 5.0% below expectations, at CN¥41b. Statutory earnings per share were relatively better off, with a per-share profit of CN¥1.42 being roughly in line with analyst estimates. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.

股东们可能已经注意到卫星化学有限公司, Ltd.(深圳证券交易所:002648)上周这个时候公布了年度业绩。早期的反应并不乐观,过去一周股价下跌3.4%,至16.68元人民币。收入比预期低5.0%,为410亿元人民币。法定每股收益相对较好,每股利润为1.42元人民币,与分析师的估计大致一致。对于投资者来说,这是一个重要时刻,因为他们可以在报告中追踪公司的业绩,看看专家对明年的预测,看看对该业务的预期是否有任何变化。根据这些结果,我们收集了最新的法定预测,以了解分析师是否改变了盈利模式。

earnings-and-revenue-growth
SZSE:002648 Earnings and Revenue Growth March 28th 2024
SZSE: 002648 收益和收入增长 2024 年 3 月 28 日

Taking into account the latest results, the current consensus from Satellite ChemicalLtd's twelve analysts is for revenues of CN¥47.4b in 2024. This would reflect a meaningful 14% increase on its revenue over the past 12 months. Per-share earnings are expected to jump 26% to CN¥1.79. Yet prior to the latest earnings, the analysts had been anticipated revenues of CN¥52.3b and earnings per share (EPS) of CN¥1.85 in 2024. It's pretty clear that pessimism has reared its head after the latest results, leading to a weaker revenue outlook and a small dip in earnings per share estimates.

考虑到最新业绩,Satellite ChemicallTD的十二位分析师目前的共识是,2024年的收入为474亿元人民币。这将反映其收入在过去12个月中大幅增长了14%。每股收益预计将增长26%,至1.79元人民币。然而,在最新财报公布之前,分析师曾预计2024年的收入为523亿元人民币,每股收益(EPS)为1.85元人民币。很明显,在最新业绩公布之后,悲观情绪已经抬头,导致收入前景疲软,每股收益预期小幅下降。

Despite the cuts to forecast earnings, there was no real change to the CN¥20.68 price target, showing that the analysts don't think the changes have a meaningful impact on its intrinsic value. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. The most optimistic Satellite ChemicalLtd analyst has a price target of CN¥25.06 per share, while the most pessimistic values it at CN¥17.30. As you can see, analysts are not all in agreement on the stock's future, but the range of estimates is still reasonably narrow, which could suggest that the outcome is not totally unpredictable.

尽管下调了预期收益,但20.68元人民币的目标股价没有实际变化,这表明分析师认为这些变化不会对其内在价值产生有意义的影响。但是,固定单一价格目标可能是不明智的,因为共识目标实际上是分析师目标股价的平均值。因此,一些投资者喜欢查看估计范围,看看对公司的估值是否有任何分歧。最乐观的Satellite ChemicalLTD分析师将目标股价定为每股25.06元人民币,而最悲观的分析师则将其估值为17.30元人民币。如你所见,分析师对该股的未来并不完全一致,但估计范围仍然相当狭窄,这可能表明结果并非完全不可预测。

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. We would highlight that Satellite ChemicalLtd's revenue growth is expected to slow, with the forecast 14% annualised growth rate until the end of 2024 being well below the historical 34% p.a. growth over the last five years. Compare this to the 484 other companies in this industry with analyst coverage, which are forecast to grow their revenue at 17% per year. So it's pretty clear that, while Satellite ChemicalLtd's revenue growth is expected to slow, it's expected to grow roughly in line with the industry.

了解这些预测的更多背景信息的一种方法是研究它们与过去的业绩相比如何,以及同一行业中其他公司的表现。我们要强调的是,Satellite ChemicallTD的收入增长预计将放缓,预计到2024年底的年化增长率为14%,远低于过去五年来历史上34%的年增长率。相比之下,该行业中其他484家拥有分析师报道的公司,预计这些公司的收入将以每年17%的速度增长。因此,很明显,尽管Satellite ChemicallTD的收入增长预计将放缓,但预计其增长将与行业大致持平。

The Bottom Line

底线

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. They also downgraded their revenue estimates, although as we saw earlier, forecast growth is only expected to be about the same as the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

要了解的最重要的一点是,分析师下调了每股收益的预期,这表明公布这些业绩后,市场情绪明显下降。他们还下调了收入预期,尽管正如我们之前看到的那样,预计增长仅与整个行业大致相同。共识目标股价没有实际变化,这表明该业务的内在价值与最新估计相比没有发生任何重大变化。

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have estimates - from multiple Satellite ChemicalLtd analysts - going out to 2026, and you can see them free on our platform here.

话虽如此,公司收益的长期轨迹比明年重要得多。多位Satellite ChemicallTD分析师估计,到2026年,你可以在我们的平台上免费查看。

You still need to take note of risks, for example - Satellite ChemicalLtd has 1 warning sign we think you should be aware of.

你仍然需要注意风险,例如——Satellite ChemicallTD有1个我们认为你应该注意的警告信号。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发